Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn’t likely coming any time soon.
Researchers have developed three new antibiotics from scorpion venom and habanero peppers to combat tuberculosis and other drug-resistant pathogens.
Bootstrap Bio and Manhattan Genomics, which were pursuing human embryo editing to prevent serious disease, have shut down.
Paterna Biosciences says it has determined the set of instructions needed to turn sperm-making stem cells into “normal, mature” sperm.
California-based startup Sabi is developing a thought-to-text wearable that could usher in the cyborg future.
Epia Neuro’s brain-computer interface will include a motorized glove to help stroke patients recover movement in their hand.
Galen Buckwalter says brain-computer interfaces will have to be enjoyable to use if the technology is going to be successful.
R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term goal, says a cofounder, is to make human versions.
While the United States and Europe are moving cautiously forward with clinical trials, China is racing toward the commercialization of brain implants.
Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology.